Rockwell MedicalRMTI +0.02%30 Forward Dividend Yield % is 0.00% as of Jun. 28, 2026. GuruFocus rates RMTI with a GF Score™ of 30/100 and a GF Value™ of $0.87 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 504 Drug Manufacturers companies, Rockwell Medical ranks worse than 198412.5% on this metric.
As of today (2026-06-28), the Forward Annual Dividend Yield of Rockwell Medical is 0.00%.
As of today (2026-06-28), the Trailing Annual Dividend Yield of Rockwell Medical is 0.00%.
RMTI's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.08 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Rockwell Medical (NAS:RMTI) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Rockwell Medical Forward Dividend Yield % Related Terms
RMTI vs MRMD, CPHI, HYEX: Forward Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rockwell Medical Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Rockwell Medical's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Rockwell Medical (RMTI) has a Forward Dividend Yield % of 0.00% as of Jun. 28, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Rockwell Medical and its competitors. According to the industry distribution chart, Rockwell Medical ranks #999999 out of 504 companies in the Drug Manufacturers industry.
Is Rockwell Medical's Forward Dividend Yield % too high?
Rockwell Medical's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Rockwell Medical ranks #999999 out of 504 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Rockwell Medical has a GF Score™ of 30/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rockwell Medical's Forward Dividend Yield % compare to MRMD and CPHI?
According to the Drug Manufacturers industry distribution chart, Rockwell Medical ranks #999999 out of 504 companies for Forward Dividend Yield %. This places Rockwell Medical in the lower half of its industry. The industry median Forward Dividend Yield % is 2.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.08, based on 504 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Rockwell Medical and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rockwell Medical's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rockwell Medical stock overvalued right now?
Based on GuruFocus' analysis, Rockwell Medical (RMTI) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.87, compared to a current price of $0.66 — trading 24.7% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Rockwell Medical's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Rockwell Medical (RMTI), the current Forward Dividend Yield % is 0.00% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rockwell Medical (RMTI) Overvalued in 2026?
Based on GuruFocus' analysis, Rockwell Medical stock appears to be undervalued.
The current stock price of $0.66 is trading 24.7% below its estimated GF Value™ of $0.87.
GuruFocus considers Rockwell Medical to be Modestly Undervalued.
Key valuation signals for RMTI:
Forward Dividend Yield %: 0.00%
GF Value™: $0.87 vs. price of $0.66 (24.7% below fair value)
No single metric tells the full story. See the RMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
30GF Score
Get the complete analysis for RMTI
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RMTI has been successfully added to your 